HCP Newsletter Archive

HCP News – June 2020

The June edition of our bi-monthly Healthcare Professionals newsletter covers the following information on neuroendocrine tumours:

  • ASCO Virtual Conference overview of neuroendocrine tumour presentations
  • CNSA Education Webinar: Demystifying NeuroEndocrine Tumours (NETs) – not as rare as you think! Tuesday 7th July 2020 @ 7PM AEST
  • NeuroEndocrine Cancer Australia bringing GP Education programs in October 2020
  • INFO4NETS “Online Triage” Support – coming soon
  • NEW online patient support group for rural patients
  • New research: Nutritional complications and the management of patients with gastroenteropancreatic neuroendocrine tumors
  • New research: Significant disease control achieved with nivolumab/temozolomide combo in neuroendocrine tumors
  • New findings: Neuroendocrine neoplasm update: toward universal nomenclature
  • Let’s Walk for NETs wrap up
  • Help us hit our target for NET research

HCP News – April 2020

The April edition of our bi-monthly Healthcare Professionals newsletter covers the following information on neuroendocrine tumours:

  • Covid-19 information, specifically for neuroendocrine tumour and cancer patients and a section dedicated to Healthcare Professional resources
  • European Neuroendocrine Tumor Society (ENETS) Virtual Conference wrap up
  • International Neuroendocrine Cancer Alliance (INCA) Virtual Summit wrap up
  • Virtual walk, “Let’s Walk for NETs”
  • Online patient support groups
  • Research paper: Economic impact on Australian patients with neuroendocrine tumours
  • Funding information: Expanded access for Sandostatin LAR
  • Outcomes from Hobart’s Upper Gastrointestinal Cancer information session 

HCP News – February 2020

PlaNET registry continues to roll out across Australia and is now coming to Royal North Shore. The first Healthcare professional forum of the year held in Wagga Wagga. Research articles on Carcinoid Heart Disease: From Pathophysiology to Treatment and Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor.

HCP News – November 2019

Cancer Council’s Consumer Forum, 8th Annual Innovations in Cancer Treatment and Care Conference. Resources available on Approaching End of Life Webinar. Some of the research articles included, the impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013–2015, research on nutritional complications and the management of patients with gastroenteropancreatic neuroendocrine tumours and many more.

HCP News – June 2019

Information on ‘Be Fair’ campaign asking the government to allocate funding to our NET Nurse program, GP Education Forum at held Norths Leagues Club, Conferences at the CNSA annual conference and the Precongress Symposium. Research around neuroendocrine carcinoma of the gall bladder, research on differentiation between non-hypervascular pancreatic neuroendocrine tumour and pancreatic ductal adenocarcinoma, research on Survival trends of metastatic small intestinal neuroendocrine tumor, research on economics of gastroenteropancreatic neuroendocrine tumors and more…

HCP News – March 2019

Information on new NET Treatment and Wellness Plan document, research on therapeutic options for neuroendocrine tumors, research on economics of gastroenteropancreatic neuroendocrine, article relating to randomised controlled trial – web-based personalised information and support for patients with a neuroendocrine tumour, and many others…

HCP News – October 2018

Information on $10 million grants through the MRFF, research relating to nose and paranasal sinuses, article re treatment of hepatic metastasis from gastroenteropancreatic NETs, research article on surgical resection for clinical stage I high-grade neuroendocrine carcinoma of the lung, case report on neuroendocrine tumor G1 of the gallbladder with lymph node metastasis, and many others .

HP News – August 2018

Information on CommNETS clinical trials workshop, research relating to self reported side effects in patients on somatostatin analogues, research update re grade 2 pancreatic NET, article outlining benefits of PARP inhibitors plus information on referrals to Molecular Screening and Therapeutics Program (MoST), and many others…

HP News – April 2018

Low survival cancer research funding announcement, call out to Health Professionals with NET cancer experience, current research articles related to small cell neuroendocrine carcinoma of nose, analysis of gastroenteropancreatic neuroendocrine tumor treatment and research on neuroendocrine carcinoma of lung, and many others…

HP News – December 2017

Update on World NET Cancer Day, introducing new Health Professionals website page, current research sourced from Journal of Global Oncology, Oncotarget, Journal of Thoracic Oncology and many others…

HP News – October 2017

Extensive research articles including “Escalated dose SSAs in management of NETs”, “The role of Cytotoxic Chemotherapy in Advanced Pancreatic NETs”, “Maintaining quality of life for patients with NETs” and many more…

HP News – July 2017

Includes research update on new neuroendocrine grading system plus news article “Lanreotide eases carcinoid syndrome symptoms in patients” and more…

HP News – May 2017

Includes research articles from “Journal of Neuroendocrine Tumors and Pancreatic Diseases and Sciences”, “Current problems in cancer”, “Journal of Gastroenterology and Hepatology”, ENETS 2017 (Barcelona) wrap up and more…

HCP Newsletter Signup

Sign up to receive our bi-monthly newsletters and direct invitations to our informative NETs webinars and events.